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Mast cell hyperplasia is often observed in dermatoses
characterized by fibrosis. Evidence has accumulated
showing that a potent fibrogenic cytokine, platelet-
derived growth factor (PDGF), plays a pathogenic role
in dermal fibrosis. To clarify the mechanism of mast cell
hyperplasia associated with fibrosis, we investigated the
effect of PDGF on mast cell proliferation and the expres-
sion of stem cell factor (SCF), a potent growth factor for
mast cells, in fibroblasts. When mouse bone marrow-
derived mast cells (BMMC) were cultured on a NIH/
3T3 fibroblast monolayer, mast cell proliferation was
stimulated in both cell number and total histamine con-
tent by all isoforms of PDGF (-AA, -AB, and -BB);
however, none of the isoforms had any effect on [3H]
thymidine incorporation in BMMC in the absence of
fibroblasts. The effect of PDGF-AB and -BB were
Mast cell hyperplasia is observed in association witha variety of dermal fibrosis, such as keloids(Sylven, 1945), healing wounds (Wichmann, 1955),hypertrophic scars (Kischer et al, 1978), andscleroderma (Nishioka et al, 1987). A pathogenic
role for activated mast cells on tissue fibrosis has been hypothesized
based on the evidence that mediators secreted from mast cells, such as
histamine, TNF-α, and tryptase, stimulate proliferation of fibroblasts
and/or collagen synthesis in fibroblasts (Hatamochi et al, 1985; Jordana
et al, 1988; Ruoss et al, 1991; Gordon and Galli, 1994; Kendall et al,
1997). On the other hand, mast cells originate from multipotent
hematopoietic stem cells in bone marrow and complete their differ-
entiation with some tissue specific characteristics in peripheral tissues
where they reside. The development of mast cells is thus strongly
influenced by the microenvironment in the peripheral tissues. The
importance of fibroblasts and a fibroblast-derived mast cell growth
factor, stem cell factor (SCF), for mast cell growth was clearly
demonstrated by using two mast cell-deficient mutant mice, W/Wv
and Sl/Sld, the former (W/Wv) lacks c-kit (SCF receptor) but has
intact SCF, and the latter (Sl/Sld) lacks SCF but has intact c-kit.
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abrogated either by the addition of anti-PDGF-AB anti-
body or by the separation of mast cells and fibroblasts
by a permeable membrane filter with a pore size of
0.2 mm. Immunoblotting of the NIH/3T3 fibroblasts
treated with PDGF revealed an enhanced expression of
SCF in the membrane fraction and the effect of PDGF
was neutralized by the addition of antibody against
SCF. Moreover, no effect of PDGF was observed when
BMMC were prepared from W/Wv mice that lack
functional c-kit as the SCF receptor or when 3T3
fibroblasts were prepared from Sl/Sld mice that lack
membrane-bound SCF. These results suggest that the
fibrogenic cytokine PDGF stimulates mast cell hyper-
plasia via the expression of membrane-bound SCF by
fibroblasts in association with fibrosis of the skin. Key
words: co-culture/fibrosis/Sl/Sld/W/Wv. J Invest Dermatol
111:213–217, 1998
Namely, co-culture of Sl/Sld-derived bone marrow mast cells and
W/Wv-derived fibroblasts resulted in proliferation of intact mast cells.
Thus the relationship between mast cells and fibroblasts in the skin is
coaffecting rather than unidirective.
A fibrogenic cytokine, platelet-derived growth factor (PDGF), which
possesses mitogenic activity for fibroblasts (Antoniades et al, 1979)
and potent enhancing activity for extracellular matrix production in
fibroblasts (Zhang and Lo, 1995), has been postulated to play a crucial
role in dermal fibrosis by the findings that PDGF production is
upregulated in the lesion of scleroderma (Gay et al, 1989) and healing
wounds (Pierce et al, 1995), and that the PDGF α-receptor is highly
expressed in fibroblasts obtained from keloids and contributes to an
enhanced response to PDGF (Haisa et al, 1994).
Therefore, even though there is no evidence for the direct effect of
PDGF on mast cell proliferation, it is feasible that PDGF is involved
in mast cell hyperplasia observed in dermal fibrosis via fibroblast
activation. To examine such a possibility, we employed a mast cell/
fibroblast co-culture system as an in vitro model of dermal mast cells
(Levi-Schaffer et al, 1985) and demonstrated that human PDGF have
significant growth-enhancing activity for mouse mast cells via induction
of membrane-bound SCF on fibroblasts.
MATERIALS AND METHODS
Animals Male, 6 wk old (WB 3 C57BL/6)F1-W/W
v (W/W v) mice and their
normal littermates (1/1) were purchased from Japan SLC (Hamamatsu, Japan).
Growth factors and antibodies Recombinant murine interleukin-3 (rmIL-
3), rmIL-4, rmSCF, and goat anti-murine SCF polyclonal antibody were
purchased from R&D systems (Minneapolis, MN). Recombinant human PDGF
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(rhPDGF)-AA, rhPDGF-AB, rhPDGF-BB, rabbit anti-human PDGF-AA poly-
clonal antibody, and goat anti-human PDGF-AB polyclonal antibody were
purchased from Upstate Biotechnology (New York, NY). Rat anti-murine
SCF monoclonal antibody was purchased from Biogenesis (Poole, U.K.).
Cell culture Bone marrow-derived mast cells (BMMC) were prepared from
6 wk old male mice according to the method described previously (Razin et al,
1981; Nakamura et al, 1994). Briefly, bone marrow cells suspended at a density
of 1 3 106 cells per ml in alpha modification of Eagle’s medium (α-MEM)
(Dainippon Pharmaceutical, Osaka, Japan) containing 10% fetal calf serum,
2 mM glutamine, 100 U penicillin G per ml, and 100 µg streptomycin per ml
(complete α-MEM) supplemented with 100 µM 2-mercaptoethanol, 5 ng
rmIL-3 per ml, and 2 ng rmIL-4 per ml, were cultured at 37°C in a
humidified atmosphere of 5% CO2 in air. Non-adherent cells were collected
by centrifugation and resuspended in fresh medium every 7 d. After 4 wk,
more than 95% of the nonadherent cells were stained positively with alcian blue.
NIH/3T3 fibroblasts were obtained from The American Type Culture Collec-
tion (CRL1658), and maintained in α-MEM containing 5% calf serum, 100 U
penicillin G per ml, and 100 µg streptomycin per ml. Sl/Sld 3T3 fibroblasts
were kindly provided by Dr. Y. Kitamura (Department of Pathology, Osaka
University Medical School, Osaka, Japan).
Co-culture of BMMC with NIH/3T3 fibroblasts BMMC/fibroblast co-
culture was performed as described previously (Levi-Schaffer et al, 1986). Briefly,
2 3 104 NIH/3T3 fibroblasts suspended in 0.5 ml of complete α-MEM were
seeded in each well of four-well multidishes (Nunc A/S, Roskilde, Denmark),
and cultured until confluence. At reaching confluence, the medium was
aspirated and 3 3 104 BMMC suspended with 500 µl of complete α-MEM
containing various concentrations of rhPDGF were added. The cells were
cultured at 37°C in a humidified atmosphere of 5% CO2 in air and the culture
medium was changed every 2 d.
In an experiment, 3 3 104 BMMC were cultured in tissue culture inserts
where they share the same medium with the NIH/3T3 fibroblasts, but were
separated by a 0.2 µm pore membrane (Anopore membrane, Nunc A/S).
Mast cell counting in co-culture Adherent cells in the co-cultures were
dispersed by incubation in trypsin-ethylenediamine tetraacetic acid solution
(0.1% trypsin and 0.01% ethylenediamine tetraacetic acid in phosphate-buffered
saline) for 10 min at 37°C, followed by addition of one-tenth volume of fetal
calf serum. The dispersed cells were washed twice with phosphate-buffered
saline and resuspended in 1 ml of phosphate-buffered saline containing 1%
bovine serum albumin. The total number of cells in the suspension was
determined using an improved Neubauer hemocytometer. Aliquots of cell
suspensions were also spun in a cytocentrifuge (1500 rpm for 1 min) and the
resulting cell preparations on slideglasses were stained with alcian blue. The
alcian blue-positive cells (mast cells) in a culture dish were calculated using the
following formula: number of mast cells per dish 5 A 3 C/B, where A is the
total number of cells in a culture dish, B is the total number of cells in a
cytocentrifuge specimen, and C is the number of alcian blue-positive cells in
the same specimen.
Determination of histamine content in co-culture Cultured cells in
each well were denatured by adding HClO4 at a final concentration of
0.25 N, and insoluble proteins were precipitated by centrifugation at
12,000 3 g at 4°C for 10 min. Histamine concentration was assayed with an
automated fluorometric-HPLC system (Tosoh, Tokyo, Japan) as described by
Tsuruta et al (1978).
Neutralization assay To neutralize activity of cytokines, antibodies were
added in the co-culture at final concentrations of 25 µg per ml for anti-PDGF-
AB antibody, 10 µg per ml for anti-PDGF-AA antibody, and 50 µg per ml for
anti-SCF antibody. After culturing for 6 d, mast cell growth was determined
by measuring histamine in the co-culture.
[3H]Thymidine incorporation BMMC were plated (1 3 104cells per well)
in wells of 96 well multiwell plates (Becton Dickinson Labware, Franklin Lakes,
NJ) with cytokines or medium alone and incubated for 36 h. Then BMMC
were pulsed with 0.5 µCi [3H]thymidine (specific activity, 5 Ci per mmol,
Dupont-New England Nuclear, Boston, MA) and further incubated for 12 h.
The cells were harvested on glass fiber filters and incorporated radioactivity in
the cells was assayed in a liquid scintillation counter (LSC5100, Aloka,
Tokyo, Japan).
Reverse transcriptase-mediated polymerase chain reaction Total RNA
was extracted from cultured cells by the guanidium thiocyanate method
(Chomczynski and Sacchi, 1987). Ten micrograms of total RNA was reverse
transcribed, and the resulting cDNA was analyzed by polymerase chain reaction
as previously described (Morita et al, 1994) with specific primers. The nucleotide
sequence of primers was as follows: murine PDGF α-receptor sense primer, 59-
TTTGTCACAGTGCTGGAAGTG-39 (nucleotide position 361–381); murine
PDGF α-receptor anti-sense primer, 59-CCAGCATGGTGATACCTTTGT-
39 (nucleotide position 884–904) (Do et al, 1992); PDGF β-receptor sense
primer, 59-AGTGTGCTGACACTG-ACCAAT-39 (nucleotide position 382–
402); PDGF β-receptor anti-sense primer, 59-GAGGCTGTAGACGTAG-
TAAGT-39 (nucleotide position 742–762) (Yarden et al, 1986). The amplified
polymerase chain reaction products were 544 bp for PDGF α-receptor and
381 bp for PDGF β-receptor.
Western blotting Quiescent, confluent cultures of 3T3 fibroblasts in 225 cm2
culture flask (Costar, Cambridge, MA) were treated with 10 ng PDGF-AB per
ml for 18 h or 36 h, washed three times with phosphate-buffered saline, and
then suspended in ice-cold extraction buffer consisting of 20 mM Tris-HCl
(pH 7.5), 2 mM ethylenediamine tetraacetic acid, 5 mM ethyleneglycol-bis(β-
aminoethyl ether)-N,N,N9,N9-tetraacetic acid, 2 mM phenylmethylsulfonyl
fluoride, and 5 mM 2-mercaptoethanol (Chida et al, 1986). The cells were
sonicated and centrifuged at 100,000 3 g for 1 h. The pellet was solubilized with
the extraction buffer containing 2% sodium dodecyl sulfate and recentrifuged at
100,000 3 g for 1 h. The resulting supernatant was referred to as membrane
fraction. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the
membrane fraction was performed according to the method described by
Laemmli (1970), and proteins in the gel were transferred to polyvinylidene
difluoride membrane (Bio-Rad Laboratories, Hercules, CA). After blocking
with 0.5% casein, the polyvinylidene difluoride membrane was treated with
10 µg per ml of anti-SCF monoclonal antibody in TBS containing 0.5% bovine
serum albumin and 0.05% Tween 20 and antibody-bound bands were visualized
with ABC-kit (Vector Laboratories, Burlingame, CA).
RESULTS
PDGF enhances mast cell growth Bone marrow cells were first
cultured in the presence of various concentrations of rhPDGF to
elucidate the direct effect of PDGF on mast cell differentiation, but
no alcian blue-positive cells containing histamine were detectable even
after 3 wk of culture (data not shown). This indicates that PDGF
itself has no direct effect on the differentiation of mast cells from
hematopoietic cells.
Dermal mast cells exist in close contact with fibroblasts (Greenberg
and Burnstock, 1983), and in vitro co-culture of BMMC with 3T3
fibroblasts is known to result in prolonged survival (Fujita et al, 1988).
Therefore, we then examined the effect of PDGF on mast cell growth
in the BMMC/fibroblast co-culture system.
When we examined mast cell growth activity in BMMC obtained
from 1/1 mice, all forms of rhPDGF (-AA, -AB, and -BB) showed
growth activity for mast cells in concentration-dependent manners
(Fig 1). The maximal growth of mast cells, however, was achieved at
a concentration of 10 ng rhPDGF-AB and -BB per ml, whereas a
higher concentration (100 ng per ml) was required for the maximal
activity of PDGF-AA. With 100 ng rhPDGF per ml, the number of
mast cells decreased, whereas histamine content remained relatively
constant, indicating a higher cellular histamine content of mast cells in
these conditions. As the histamine content per cell was found to be
constant throughout the co-culture in a range from 0 to 10 ng rhPDGF
per ml, an increase of total histamine content in the wells is considered
to represent the increase of mast cell number. Thus the total histamine
contents were measured for mast cell proliferation assay in the following
experiments. With 10 ng rhPDGF-AB and -BB per ml, histamine
content in co-cultures increased until 4 d culture, and remained
relatively constant thereafter as shown in Fig 2.
Addition of anti-PDGF-AB antibody (final concentration of 25 µg
per ml) completely abolished the growth of mast cells induced by both
rhPDGF-AB and -BB (Table I). Anti-PDGF-AA antibody (final
concentration of 10 µg per ml) partially inhibited the effect of rhPDGF-
AB, whereas the effect of rhPDGF-BB was not affected (Table I).
In order to see direct mitogenic activity of PDGF on BMMC,
[3H]thymidine incorporation in BMMC obtained from 1/1 mice
was assayed in the presence of a series of concentrations of rhPDGF.
Treatment with rhPDGF (-AA, -AB, and -BB) failed to stimulate
DNA synthesis of BMMC, although rmSCF was enhanced significantly
(Table II).
Expression of PDGF receptor mRNA in BMMC and 3T3 fibroblasts
was investigated by reverse transcriptase polymerase chain reaction.
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Figure 1. rhPDGF-AA, -AB, and -BB induced mast cell growth. BMMC
obtained from 1/1 mice were co-cultured with NIH/3T3 fibroblasts in the
presence of a series of concentrations of PDGF, and histamine contents (A) and
the number of mast cells (B) were determined on day 6. Data are mean 6 SEM
of three experiments done in duplicate (*p , 0.05, **p , 0.01).
Figure 2. Time-dependent mast cell growth induced by rhPDGF-AB
and -BB. BMMC obtained from 1/1 mice were co-cultured with NIH/
3T3 fibroblasts in the presence of 10 ng rhPDGF-AB or rhPDGF-BB per ml,
and histamine content in the co-culture was determined on the indicated days.
One typical experiment from three experiments performed independently
is shown.
Because the PDGF receptor is composed of a combination of two
distinct subunits, α and β (Kelly et al, 1991), we prepared two sets of
primers specific for the α subunit and the β subunit. When total RNA
from BMMC obtained from 1/1 mice was analyzed for mRNA
expression of the α and β subunits, only β subunit mRNA was
detected (Fig 3). In contrast, both α and β subunit mRNA were
detected in 3T3 fibroblasts (Fig 3).
PDGF requires close range cell interactions for mast cell
growth To investigate whether adhesion to fibroblasts is essential
for the growth of BMMC caused by PDGF, BMMC obtained from
Table I. Neutralization assay by using anti-PDGF antibodya
Without antibodies Anti-PDGF-AA Anti-PDGF-AB
Medium 28.3 6 2.0b 29.4 6 1.6 22.5 6 1.1
rhPDGF-AB 51.6 6 5.8 43.5 6 3.5 30.3 6 1.8
rhPDGF-BB 68.0 6 3.5 82.6 6 4.0 31.5 6 1.4
a BMMC obtained from 1/1 mice were co-cultured with NIH/3T3 fibroblasts in the
presence of 10 ng rhPDGF-AB per ml or 10 ng rhPDGF-BB per ml for 6 d. Specificity
in mast cell growth activity was examined by adding anti-PDGF-AA antibody (10 µg per
ml) or anti-PDGF-AB antibody (25 µg per ml).
b Growth of BMMC was determined by total cellular histamine (ng per well). Data are
mean 6 SEM of three experiments done in duplicate.
Table II. [3H]Thymidine incorporation in BMMC treated
with cytokines
Cytokines [3H]Thymidine incorporation (cpm)a
Medium 231.38 6 214.93
rmSCF (10 ng per ml) 3611 6 258.46b
rhPDGF-AA (10 ng per ml) 148.67 6 86.33
rhPDGF-AB (10 ng per ml) 167.83 6 77.98
rhPDGF-BB (10 ng per ml) 123.33 6 94.62
a Data are mean 6 SEM of three experiments done in triplicate.
b p,0.01 versus medium control.
Figure 3. Expression of PDGF receptor (a- and b-subunit) mRNA in
BMMC and 3T3 fibroblasts analyzed by reverse transcriptase polymerase
chain reaction. Total RNA was extracted from NIH/3T3 fibroblasts and
BMMC obtained from 1/1 mice, reverse transcribed, and analyzed by
polymerase chain reaction with specific primers for PDGF α-receptor and
PDGF β-receptor. The amplified polymerase chain reaction products were
544 bp for PDGF α-receptor and 381 bp for PDGF β-receptor.
1/1 mice were cultured separated from 3T3 fibroblasts by a 0.2 µm
pore membrane. Under these conditions, both rhPDGF-AB and -BB
showed no significant mast cell growth activity (Fig 4).
PDGF enhances the expression of membrane-bound SCF on
3T3 fibroblasts Because SCF is a well-characterized mast cell growth
factor existing predominantly as a membrane-bound form on fibroblasts
(Flanagan and Leder, 1990), we assessed whether PDGF-induced mast
cell growth was associated with SCF induction from 3T3 fibroblasts
by anti-SCF antibody, W/Wv, a mutant mouse with dysfunction of
SCF receptor-derived mast cells, 3T3 fibroblasts prepared from Sl/Sld
mice that lack membrane-bound SCF, and western immunoblotting
for SCF. First, addition of 50 µg per ml (at final concentration) of anti-
SCF antibody into the BMMC/3T3 fibroblast co-culture abrogated all
effects of PDGF-BB and SCF, reducing histamine content down to
that in cells cultured with medium alone in the presence of the
antibody (Table III).
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Figure 4. Separation of mast cells from fibroblasts by using 0.2 mm
pore membrane abrogated the mast cell growth induced by PDGF.
BMMC obtained from 1/1 mice were cultured with NIH/3T3 fibroblasts
either with or without tissue culture inserts attached with 0.2 µm pore
membrane, and stimulated with 10 ng rhPDGF-AB per ml or 10 ng rhPDGF-
BB per ml. PDGF-containing complete α-MEM was added into both the inner
and the outer sides of the inserts at the starting of the co-culture. Culture
medium of the outer side was replaced on days 2 and 4, then BMMC in the
inserts were harvested on day 6. Data are mean 6 SEM of three experiments
done in duplicate.
Table III. Anti-SCF antibody reduced the mast cell growth
induced by PDGF-BBa
Without antibody Anti-SCF antibody
Medium 22.7 6 2.2b 11.2 6 7.9
rhPDGF-BB 63.0 6 2.6 13.6 6 8.3
rmSCF 68.5 6 7.4 14.2 6 9.5
a BMMC obtained from 1/1 mice were co-cultured with NIH/3T3 fibroblasts in the
presence of 20 ng rhPDGF-BB per ml or 10 ng rm SCF per ml for 6 d. Anti-SCF
antibody was added in final concentration of 50 µg per ml.
b Growth of BMMC was determined by total cellular histamine (ng per well). Data are
mean 6 SEM of three experiments done in duplicate.
Table IV. The co-culture of W/Wv mice derived mast cells
with 3T3 fibroblastsa
Concentration (ng per mnl)
1 10 100
rhPDGF-AA 7.0 6 1.7b 7.2 6 2.8 9.4 6 3.8
rhPDGF-AB 6.5 6 1.1 7.7 6 2.0 9.5 6 4.1
rhPDGF-BB 8.3 6 3.5 7.1 6 2.1 9.0 6 3.7
Medium 7.9 6 4.1
IL-3,4c 33.7 6 10.9
a BMMC obtained from W/W v mice were co-cultured with NIH/3T3 fibroblasts in
the presence of various concentration of PDGF for 6 d.
b Growth of BMMC was determined by total cellular histamine (ng per well). Data are
mean 6 SEM of three experiments done in duplicate.
c Complete α-MEM containing 5 ng rmIL-3 per ml and 2 ng rmIL-4 per ml.
Second, rhPDGF-AB and -BB showed no significant effect on the
growth of W/Wv mice-derived mast cells in the co-culture with intact
fibroblasts in a range from 1 to 100 ng per ml (Table IV), and
rhPDGF-BB showed no significant growth of 1/1 mice-derived mast
cells in the co-culture with Sl/Sld mice-derived fibroblasts (Table V).
Finally, we treated 3T3 fibroblasts with 10 ng rhPDGF-AB per ml
and analyzed their membrane fractions by immunoblotting with anti-
SCF monoclonal antibody. The treatment of rhPDGF-AB induced a
significant amount of SCF protein after 18 h and it further increased
after 36 h (Fig 5).
Table V. The co-culture of 1/1 mice-derived mast cells with
Sl/Sl d mice-derived fibroblastsa
Sl/Sld fibroblasts 3T3 fibroblasts
Medium 7.2 6 4.2b 22.7 6 2.2
rhPDGF-BB 11.8 6 2.7 63.0 6 2.6
rmSCF 61.5 6 6.2 68.5 6 7.6
a BMMC obtained from 1/1 mice were co-cultured with Sl/Sld derived fibrobasts in
the presence f 20 ng rhPDGF-BB per ml or 10 ng rmSCF per ml for 6 d.
b Growth of BMMC was determined by total cellular histamine (ng per well). Data are
mean 6 SEM of three experiments done in duplicate.
Figure 5. SCF expression in 3T3 fibroblasts was enhanced by PDGF.
Confluent NIH/3T3 fibroblasts were either untreated or stimulated with 10 ng
rhPDGF-AB per ml, and the membrane fraction was extracted after 18 h or
36 h. SCF associated with membrane fraction was visualized by western blotting
with anti-SCF monoclonal antibody.
DISCUSSION
PDGF is one of the major connective tissue cell-growth factors present
in serum and platelets. It exists as a dimer of two homologous
polypeptides, A and B, and three forms of isoforms, AA, AB, and BB,
have been identified (Betsholtz et al, 1986). Likewise, PDGF receptors
consist of two subunits, α and β, which are dimerized into αα, αβ,
and ββ on activation (Yarden et al, 1986; Kelly et al, 1991; Do et al,
1992). Although the α-receptor subunit binds all three isoforms of
PDGF, the β-receptor subunit binds only PDGF-BB isoform with
high affinity and PDGF-AB isoforms with low affinity (Hart et al,
1988; Seifert et al, 1989). In this study, we demonstrated that all three
isoforms of rhPDGF showed growth activity for mast cells in a BMMC/
3T3 fibroblast co-culture system, although the effect of PDGF-AA
was somewhat lower than those of the other isoforms (Figs 1, 2,
Table I). These results suggest the major involvement of PDGF-AB,
PDGF-BB, and the β subunit of the PDGF receptors, but clearly
indicated the involvement of all PDGF polypeptides, A and B, and
their receptor subunits, α and β, in the reaction. Therefore, the effect
of PDGF is hardly attributable to its direct action on BMMC, which
only express mRNA for the β subunit of the PDGF receptors (Fig 3).
Moreover, neither rhPDGF-AA, rhPDGF-AB, nor rhPDGF-BB
stimulated [3H]thymidine incorporation into the BMMC in the
absence of fibroblasts, which express mRNA for both α and β
subunits of the PDGF receptors, suggesting the crucial involvement of
fibroblasts in PDGF induced mast cell proliferation (Table II).
In contrast to our results, de Parseval et al (1993) reported that
PDGF-BB shows growth activity for mast cell line cells, which were
established from murine bone marrow, through the PDGF β-receptor.
A possible explanation is the different culture conditions for mast cells,
as de Parseval et al used long-term cultured mast cells established as a
cell line in which mast cells might be different from our freshly
obtained BMMC in functions of the PDGF β-receptor.
The experiment of BMMC/3T3 fibroblast separation by using
0.2 µm pore membrane indicates that PDGF-induced mast cell growth
needs direct contact with fibroblasts (Fig 4). This result reminded us
of a membrane-bound mast cell growth factor, SCF, which is the best
characterized growth factor for mast cells expressed on stromal cells,
such as fibroblasts. To determine whether SCF is involved in PDGF-
induced mast cell growth in the BMMC/fibroblast co-culture system,
we added anti-SCF antibody to the co-culture system and found that
mast cell growth induced by rhPDGF was completely inhibited by the
anti-SCF antibody. Moreover, mast cells derived from W/Wv mice,
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which is a functionally defective c-kit (Nocka et al, 1990), showed no
significant growth response to rhPDGF (Table IV). In addition,
rhPDGF also failed to enhance mast cell growth in the co-culture of
normal (1/1 mouse-derived) BMMC with fibroblasts derived from
Sl/Sld mice, which lack membrane-bound SCF (Flanagan and Leder,
1990) (Table V). These results imply that PDGF enhances proliferation
of BMMC mainly, if not totally, by upregulating SCF expression on
3T3 fibroblasts. This was further supported by an immunoblot in
which the quantity of membrane-bound SCF protein of 3T3 fibroblast
monolayer was upregulated by rhPDGF-AB in a time-dependent
manner (Fig 5). This upregulation was likely to be associated with
growth of 3T3 fibroblasts themselves, because the enhancement of
mast cell growth was abolished when 3T3 fibroblast monolayer was
pretreated with mitomycin C (50 µg per ml for 30 min), which
completely blocked cell proliferation (data not shown).
Proliferation of mast cells in tissue has been mainly considered to
be mediated by T cell-derived soluble cytokines, such as IL-3 and IL-
4. In fact, Nippostrongylus bradiliensis-infected mice show remarkable
mastocytosis in intestine and this mastocytosis was suppressed by
antibodies to IL-3 and IL-4 (Madden et al, 1991); however, PDGF
induced mRNA for neither IL-3 nor IL-4 in 3T3 fibroblasts when
analyzed by reverse transcriptase polymerase chain reaction (data not
shown), further endorsing the importance of SCF on fibroblasts in
PDGF-induced mast cell proliferation. Our results introduce a new
pathway in the mechanism of mast cell hyperplasia in skin, in which
PDGF enhances mast cell growth through upregulation of the SCF
expression in fibroblasts. PDGF may thus play an important role in
not only dermal fibrosis, but also in fibrosis-associated mast cell
hyperplasia.
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